{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:47:46Z","timestamp":1763959666654},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>We examined whether the apparent association between renal cell carcinoma (RCC) and use of dihydropyridine calcium channel blockers (CCBs) was explained by confounding by indication since hypertension, the main indication for CCBs, is a risk factor for RCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using Danish health registries, we conducted a nested case-control study including 7315 RCC cases during 2000\u20132015. We matched each case with up to 20 controls on age and sex using risk-set sampling. We estimated odds ratios (ORs) for long-term CCB use associated with RCC using conditional logistic regression. We addressed confounding by indication by (1) adjusting for hypertension severity indicators; (2) evaluating dose-response patterns; (3) examining whether other first-line anti-hypertensives were associated with RCC; and (4) using an active comparator new user design by nesting the study in new users of CCBs or angiotensin-converting enzyme inhibitors (ACEIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The adjusted OR for RCC associated with long-term CCB use compared to non-use was 1.76 (1.63\u20131.90). After we additionally adjusted for hypertension severity indicators, the OR remained elevated (OR 1.37; confidence interval [CI] 1.25, 1.49) with evidence of a dose-response pattern. Other anti-hypertensives were also associated with RCC, for example, ACEIs (OR 1.27; 95% CI = 1.16, 1.39) and thiazides (OR 1.22; 95% CI = 1.12, 1.34). In the active comparator new user design, the OR was 1.21 (95% CI = 0.95, 1.53) for use of CCBs compared with ACEIs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this population, confounding by indication appeared to explain at least part of the association between RCC and dihydropyridine CCBs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001256","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T21:00:47Z","timestamp":1599426047000},"page":"860-871","source":"Crossref","is-referenced-by-count":7,"title":["Risk of Renal Cell Carcinoma Associated with Calcium Channel Blockers"],"prefix":"10.1097","volume":"31","author":[{"given":"Kasper Bruun","family":"Kristensen","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel A.","family":"Habel","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J.","family":"Gagne","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[{"name":"Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus Kaae","family":"Andersen","sequence":"additional","affiliation":[{"name":"Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality.","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur Urol"},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer.","volume":"7","author":"Chow","year":"2010","journal-title":"Nat Rev Urol"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.eururo.2006.11.056","article-title":"Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.","volume":"51","author":"Verhoest","year":"2007","journal-title":"Eur Urol"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ebiom.2016.03.018","article-title":"Identification of associations between prescribed medications and cancer: a nationwide screening study.","volume":"7","author":"Potteg\u00e5rd","year":"2016","journal-title":"EBioMedicine"},{"key":"R5-20230908","first-page":"327","article-title":"Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension.","volume":"4","author":"Chow","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/bjc.1998.248","article-title":"Hypertension, obesity and their medications in relation to renal cell carcinoma.","volume":"77","author":"Yuan","year":"1998","journal-title":"Br J Cancer"},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","article-title":"Obesity, hypertension, and the risk of kidney cancer in men.","volume":"343","author":"Chow","year":"2000","journal-title":"N Engl J Med"},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.bjc.6603823","article-title":"Blood pressure and renal cancer risk: the HUNT Study in Norway.","volume":"97","author":"Vatten","year":"2007","journal-title":"Br J Cancer"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/aje\/kwm321","article-title":"Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition.","volume":"167","author":"Weikert","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","article-title":"Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women.","volume":"63","author":"Sanfilippo","year":"2014","journal-title":"Hypertension"},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.2910630212","article-title":"International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension.","volume":"63","author":"McLaughlin","year":"1995","journal-title":"Int J Cancer"},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer.","volume":"279","author":"Rosenberg","year":"1998","journal-title":"JAMA"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.aje.a009848","article-title":"Hypertension, antihypertensive medication use, and risk of renal cell carcinoma.","volume":"149","author":"Shapiro","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.bjc.6602490","article-title":"A cohort study of antihypertensive treatments and risk of renal cell cancer.","volume":"92","author":"Fryzek","year":"2005","journal-title":"Br J Cancer"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10552-017-0857-3","article-title":"Antihypertensive medication use and risk of renal cell carcinoma.","volume":"28","author":"Colt","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"7 Suppl","key":"R16-20230908","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry.","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology.","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"R18-20230908","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7 suppl","key":"R20-20230908","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish Education Registers.","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Public Health"},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.4145","article-title":"New use of prescription drugs prior to a cancer diagnosis.","volume":"26","author":"Potteg\u00e5rd","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S59156","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012.","volume":"6","author":"Schmidt","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"e3645","DOI":"10.1136\/bmj.e3645","article-title":"The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.","volume":"344","author":"Azoulay","year":"2012","journal-title":"BMJ"},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/EDE.0000000000000221","article-title":"The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case-control.","volume":"26","author":"Suissa","year":"2015","journal-title":"Epidemiology"},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","article-title":"A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.","volume":"63","author":"Bosco","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R30-20230908","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1467-789X.2006.00291.x","article-title":"Prevalence of obesity in Denmark.","volume":"8","author":"Due","year":"2007","journal-title":"Obes Rev"},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jash.2008.08.001","article-title":"Prevalence, awareness, and control of arterial hypertension in Denmark.","volume":"3","author":"Kronborg","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"R33-20230908","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"R34-20230908","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.20618","article-title":"Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies.","volume":"114","author":"Hunt","year":"2005","journal-title":"Int J Cancer"},{"key":"R35-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","article-title":"The incident user design in comparative effectiveness research.","volume":"22","author":"Johnson","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R36-20230908","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/aje\/kwv269","article-title":"Performance of disease risk score matching in Nested Case-Control Studies: a simulation study.","volume":"183","author":"Desai","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"suppl 1","key":"R37-20230908","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pds.4708","article-title":"Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.","volume":"29","author":"Secrest","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R38-20230908","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/sim.5686","article-title":"Methods for dealing with time-dependent confounding.","volume":"32","author":"Daniel","year":"2013","journal-title":"Stat Med"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T11:22:01Z","timestamp":1694172121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001256"}},"subtitle":["A Nationwide Observational Study Focusing on Confounding by Indication"],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001256","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}